These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 18768867)

  • 1. Impact of a three amino acid deletion in the CH2 domain of murine IgG1 on Fc-associated effector functions.
    Baudino L; Nimmerjahn F; Shinohara Y; Furukawa J; Petry F; Verbeek JS; Nishimura S; Ravetch JV; Izui S
    J Immunol; 2008 Sep; 181(6):4107-12. PubMed ID: 18768867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential contribution of three activating IgG Fc receptors (FcgammaRI, FcgammaRIII, and FcgammaRIV) to IgG2a- and IgG2b-induced autoimmune hemolytic anemia in mice.
    Baudino L; Nimmerjahn F; Azeredo da Silveira S; Martinez-Soria E; Saito T; Carroll M; Ravetch JV; Verbeek JS; Izui S
    J Immunol; 2008 Feb; 180(3):1948-53. PubMed ID: 18209093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crucial role of aspartic acid at position 265 in the CH2 domain for murine IgG2a and IgG2b Fc-associated effector functions.
    Baudino L; Shinohara Y; Nimmerjahn F; Furukawa J; Nakata M; Martínez-Soria E; Petry F; Ravetch JV; Nishimura S; Izui S
    J Immunol; 2008 Nov; 181(9):6664-9. PubMed ID: 18941257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Galactosylation of IgG1 modulates FcγRIIB-mediated inhibition of murine autoimmune hemolytic anemia.
    Yamada K; Ito K; Furukawa J; Nakata J; Alvarez M; Verbeek JS; Shinohara Y; Izui S
    J Autoimmun; 2013 Dec; 47():104-10. PubMed ID: 24055197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III.
    Fossati-Jimack L; Ioan-Facsinay A; Reininger L; Chicheportiche Y; Watanabe N; Saito T; Hofhuis FM; Gessner JE; Schiller C; Schmidt RE; Honjo T; Verbeek JS; Izui S
    J Exp Med; 2000 Apr; 191(8):1293-302. PubMed ID: 10770797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Both FcgammaRIV and FcgammaRIII are essential receptors mediating type II and type III autoimmune responses via FcRgamma-LAT-dependent generation of C5a.
    Syed SN; Konrad S; Wiege K; Nieswandt B; Nimmerjahn F; Schmidt RE; Gessner JE
    Eur J Immunol; 2009 Dec; 39(12):3343-56. PubMed ID: 19795417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FcgammaRIV: a novel FcR with distinct IgG subclass specificity.
    Nimmerjahn F; Bruhns P; Horiuchi K; Ravetch JV
    Immunity; 2005 Jul; 23(1):41-51. PubMed ID: 16039578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of Murine IgG1 and Human IgG4 to Inhibit the Classical Complement and Fcγ Receptor Activation Pathways.
    Lilienthal GM; Rahmöller J; Petry J; Bartsch YC; Leliavski A; Ehlers M
    Front Immunol; 2018; 9():958. PubMed ID: 29867943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperacute rejection by anti-Gal IgG1, IgG2a, and IgG2b is dependent on complement and Fc-gamma receptors.
    Ding JW; Zhou T; Zeng H; Ma L; Verbeek JS; Yin D; Shen J; Chong AS
    J Immunol; 2008 Jan; 180(1):261-8. PubMed ID: 18097027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An engineered Fc variant of an IgG eliminates all immune effector functions via structural perturbations.
    Vafa O; Gilliland GL; Brezski RJ; Strake B; Wilkinson T; Lacy ER; Scallon B; Teplyakov A; Malia TJ; Strohl WR
    Methods; 2014 Jan; 65(1):114-26. PubMed ID: 23872058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fc gamma RIII and Fc gamma RIV are indispensable for acute glomerular inflammation induced by switch variant monoclonal antibodies.
    Giorgini A; Brown HJ; Lock HR; Nimmerjahn F; Ravetch JV; Verbeek JS; Sacks SH; Robson MG
    J Immunol; 2008 Dec; 181(12):8745-52. PubMed ID: 19050295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysine 322 in the human IgG3 C(H)2 domain is crucial for antibody dependent complement activation.
    Thommesen JE; Michaelsen TE; Løset GÅ; Sandlie I; Brekke OH
    Mol Immunol; 2000 Nov; 37(16):995-1004. PubMed ID: 11395138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular and cellular basis for pathogenicity of autoantibodies: lessons from murine monoclonal autoantibodies.
    Baudino L; Azeredo da Silveira S; Nakata M; Izui S
    Springer Semin Immunopathol; 2006 Oct; 28(2):175-84. PubMed ID: 16953439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complement activation selectively potentiates the pathogenicity of the IgG2b and IgG3 isotypes of a high affinity anti-erythrocyte autoantibody.
    Azeredo da Silveira S; Kikuchi S; Fossati-Jimack L; Moll T; Saito T; Verbeek JS; Botto M; Walport MJ; Carroll M; Izui S
    J Exp Med; 2002 Mar; 195(6):665-72. PubMed ID: 11901193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc.
    Idusogie EE; Presta LG; Gazzano-Santoro H; Totpal K; Wong PY; Ultsch M; Meng YG; Mulkerrin MG
    J Immunol; 2000 Apr; 164(8):4178-84. PubMed ID: 10754313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro functional characterization of feline IgGs.
    Strietzel CJ; Bergeron LM; Oliphant T; Mutchler VT; Choromanski LJ; Bainbridge G
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):214-23. PubMed ID: 24560097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcγRIV deletion reveals its central role for IgG2a and IgG2b activity in vivo.
    Nimmerjahn F; Lux A; Albert H; Woigk M; Lehmann C; Dudziak D; Smith P; Ravetch JV
    Proc Natl Acad Sci U S A; 2010 Nov; 107(45):19396-401. PubMed ID: 20974962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycine 236 in the Lower Hinge Region of Human IgG1 Differentiates FcγR from Complement Effector Function.
    Brinkhaus M; Douwes RGJ; Bentlage AEH; Temming AR; de Taeye SW; Tammes Buirs M; Gerritsen J; Mok JY; Brasser G; Ligthart PC; van Esch WJE; Verheesen P; de Haard H; Rispens T; Vidarsson G
    J Immunol; 2020 Dec; 205(12):3456-3467. PubMed ID: 33188070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fc
    Qiu A; Miller A; Zotti FD; Santhanakrishnan M; Hendrickson JE; Tredicine M; Stowell SR; Luckey CJ; Zimring JC; Hudson KE
    Front Immunol; 2022; 13():972723. PubMed ID: 36189253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IgG subclasses determine pathways of anaphylaxis in mice.
    Beutier H; Gillis CM; Iannascoli B; Godon O; England P; Sibilano R; Reber LL; Galli SJ; Cragg MS; Van Rooijen N; Mancardi DA; Bruhns P; Jönsson F
    J Allergy Clin Immunol; 2017 Jan; 139(1):269-280.e7. PubMed ID: 27246523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.